AstraZeneca and Oracle team up on AI to find patients for drug trials

AstraZeneca and Oracle have partnered to use AI and anonymized patient data to accelerate recruitment for drug trials, starting with a hypertension program in Abu Dhabi and expanding globally to other diseases. The collaboration aims to reduce trial times and costs by identifying suitable patients earlier while ensuring privacy and ethics compliance.